Work

Ab0469 Efficacy and Safety of Secukinumab in Chinese Patients With Active Psoriatic Arthritis: Week 16 Results From a Phase Iii, Randomised, Double-blind, Placebo-controlled Bridging Study in China

Year: 2024

Type: conference-abstract

Source: Annals of the Rheumatic Diseases

DOI: 10.1136/annrheumdis-2024-eular.5374

Authors: X. Leng, Y. Liu, L. Tang, L. Sun, J. LI, J. Hu, H. LI, S. Ye, L. Wu, X. Duan, H. Liu, T. LI, Y. Wang, M. Bustamante, S. Kaur, R. Martin, R. Fu, Y. Tian, J. Yang, P. Pellet, X. Zeng

Language: English

Topic: Spondyloarthritis Studies and Treatments

Subfield: Rheumatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4401231228

Cites:

Cited by:

Related to: 10